Infection by Staphylococcus lugdunensis: Clinicomicrobiologic characterization of 25 cases;Infeccion por Staphylococcus lugdunensis: Caracterizacion clinicomicrobiologica de 25 casos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 5, 1999, Pages 223-226

  Ros, María Jesús ^a   Ramírez, Antonio ^a   Arteaga, Emilio ^a   Alberto, Concepción ^a   Gil, José ^a   Reina, Jordi ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Bacteremia; Coagulase negative staphylococcus; Infection; Mastiffs; Staphylococcus lugdunensis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT; COAGULASE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MASTITIS; MINIMUM INHIBITORY CONCENTRATION; SPECIES DIFFERENCE; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCUS;

ADULT; ANTI-BACTERIAL AGENTS; COAGULASE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 0345711459     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Freney J, Brun Y, Bes M, Meugnier H, Grimont F, Grimont PAD et al. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Bacteriol 1988; 38: 168-172.
2. Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 1991; 29: 419-421.
3. Kleeman KT, Bannerman TL, Kloos WE. Species distribution of coagulase-negative-staphylococcal isolates at a comunity hospital and implications for selection of staphylococcal identification procedures. J Clin Microbiol 1993; 31: 1.318-1.321.
4. Etienne J, Brun Y, Fleurette J. Staphylococcus lugdunensis endocarditis. J Clin Pathol 1989; 42: 892-893.
5. Ludlam H, Phillips I. Staphylococcus lugdunensis peritonitis [carta]. Lancet 1989; 2: 1.394.
6. Palazzo E, Pierre J, Besbes N, Staphylococcus lugdunensis arthritis: a complication of arthroscopy [carta]. J Rheumatol 1992; 19: 327-328.
7. Schonheyder HC, Hansen VK, Asschenfeldt P, Rosdhal VT. Staphylococcus lugdunensis: an important cause of endocarditis. A case report. AP-MIS 1993; 101: 802-804.
8. Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 1993; 17: 871-876.
9. Waghorn DJ. Staphylococcus lugdunensis as a cause of breast abscess. Clin Infect Dis 1994; 19: 814-815.
10. Murdoch DR, Everts RJ, Chambers ST, Cowan IA. Vertebral osteomyelitis due to Staphylococcus lugdunensis. J Clin Microbiol 1996; 34: 993-994.
11. Ruiz L, Corbella X, Agullo JL, Verdaguer R, Cabo X. Pubic osteitis caused by Staphylococcus lugdunensis. Enferm Infecc Microbiol Clin 1998; 16: 152-153.
12. Uriel JA, Aisa ML, Marco ML, Fortuno B, Torres L. Cesarean scar abscess caused by Staphylococcus lugdunensis. Enferm Infecc Microbiol Clin 1996; 14: 631-632.
13. Gómez-Rodríguez N, González-Mediero G, Ibáñez-Ruan J, Formigo E. Cellulitis and lymphangitis caused by Staphylococcus lugdunensis. Enferm Infecc Microbiol Clin 1996; 14: 457.
14. Lambe DW Jr, Ferguson KP, Keplinger JL, Gemmell CG, Kalbfleisch JH. Pathogenicity of Staphylococcus lugdunensis. Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can J Microbiol 1990; 36: 455-463.
15. Ferguson KP, Lambe DW Jr, Keplinger JL, Kalbfleisch JH. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can J Microbiol 1991; 37: 722-724.
16. Paulsson M, Petersson AC, Ljungh A. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J Med Microbiol 1993; 38: 96-102.
17. a ed.). Washington DC: American Society for Microbiology, 1995; 282-298.
18. Smyth EG, Wright ED, Marplcs RR. New type of Staphylococcal endocarditis. J Clin Pathol 1988; 41: 809-810.
19. Walsh B, Mounsey JP. Staphylococcus lugdunensis and endocarditis. J Clin Pathol 1990; 43: 171-173.
20. Costello R, Miquel M, Gastaut JA, Bouabdallah R. Native valve Staphylococcus lugdunensis endocarditis in a patient with lynphoma [carta]. Ann Med Interne (París) 1995; 146: 369.
21. Fleurette JM, Bes M, Brun Y, Freney J, Forey F, Coulet et al. Clinical isolates of Staphylococcus lugdunensis and S. shleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol 1989; 140: 107-118.
22. Llinares P, Moure R, Cerqueiro J, Abalde M, Míguez E, Echaniz A et al. Endocarditis por Staphylococcus lugdunensis. Incidencia hospitalaria. Enferm Infecc Microbiol Clin 1998; 16: 233-236.
23. Lina B, Vandenesch F, Reverdy ME, Greenland T, Fleurette J, Etienne J. Non-puerperal breast infections due to Staphylococcus lugdunensis [carta]. Eur J Clin Microbiol Infect Dis 1994; 13: 686-687.
24. Surani S, Chandra H, Weinstein RA. Breast abscess: coagulase-negative Staphylococcus as a sole pathogen. Clin Infect Dis 1993; 17: 701-704.
25. Ortíz de la Tabla V, Gutiérrez-Rodero F, Martín C, Zorraquino A, Belinchon I. Staphylococcus lugdunensis as a cause of abscesses in the perineal area. Eur J Clin Microbiol Infect Dis 1996; 15: 405-407.
26. Herchline TE, Barnishan J, Ayers LW, Fass RJ. Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis. Antimicrob Agents Chemother 1990; 34: 2.434-2.435.